Former HPIC customers DJS Antibodies has just been acquired by AbbVie for $255 million
Congratulations to DJS Antibodies, a biotechnology company dedicated to creating the next generation of antibody therapeutics, who started life at HPIC using shared lab bench space and have just been acquired by AbbVie for $255 million.
HPIC are currently asking bio tech start-ups to apply for the opportunity to secure free bench-space for one-year.
Could you be the next DJS Antibodies?
Incredible opportunity to be part of an inspiring Oxfordshire bio-science community.
Find out more here about HPIC Bio-tech bench-space opportunity. Deadline for applications is 13th November.
Joe Illingworth, Chief Scientific Officer and Co-founder of DJS Antibodies, said: “DJS was based at Heyford Park Innovation Centre for five years and if it wasn’t for the centre, the company would not exist. The cost of setting-up a lab is unachievable for start-ups and there are very few places that offer shared lab space in Oxfordshire and across the UK. The Oxford Innovation Space team should feel immensely proud of the unique service they provide, which is also supported by a collaborative and growing community of like-minded people.”
DJS, is working on new therapeutics to treat the world’s most critical inflammatory diseases, a class of disease that accounts for more than 50 per cent of deaths worldwide. With very limited start-up funding the two founders initially used their bench in shifts, with one using the bench in the daytime and the other using it in the evening.
Trudy Franklin-Slattery, HPIC Centre Manager said: “We couldn’t be more delighted for DJS Antibodies and what an incredible success story to go from quite literally working around the clock and sharing lab bench space, to establishing a successful growing business that could have such a positive impact on lives. They thoroughly deserve this success and we’re incredibly proud to be part of their journey.”
Heyford Park Innovation Centre is a fully equipped 3,000 sq. ft. managed laboratory and office facility that includes Containment Level 2 laboratories, a combined shared lab, a fully equipped cell-culture and microbiology lab along with use of a range of lab equipment and general consumables. Companies also receive business support from a Business Innovation Director support, as well as Lab Supervisor support.
You can read more about the acquisition of DJS Antibodies here:
More Blog Articles
ConserV Bioscience grows team of vaccine specialists
ConserV Bioscience Ltd specialises in the development of vaccines against human diseases. The company was created in October 2020 as a spin out of the parent company PepTcell, so they have just celebrated their third anniversary. They have a large portfolio of vaccine candidates in different stages of development. Their […]
We are proud to see our graduated customers continuing to grow and succeed
Which is why we’d like to congratulate FitnessGenes on their earning of the prestigious Cherwell Business Award. Oxford Technology Park proudly announces FitnessGenes as the recipient of the prestigious Cherwell Business Awards Innovation Award. As the sponsor of this esteemed award, Oxford Technology Park extend a heartfelt congratulations to FitnessGenes for their outstanding contribution to innovation in […]
Our customer Nikalyte have expanded their manufacturing capability
At Heyford Park Innovation Centre, we pride ourselves on our flexibility with our customers and their spaces, even enabling our customers to knock walls down to create doorways in order to continue advancing their projects. Our customer Nikalyte have expanded their manufacturing capability at their Heyford Park Innovation Centre home […]